Berz, D., Morgensztern, D., Sanborn, R. E., Atkinson, T. S., Jotte, R. M., Konduri, K., Richards, D. A., Spira, A. I., Berger, M. S. (2026). Predictive biomarkers for PFS in patients receiving quaratusugene ozeplasmid.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.e15184